Search

everythinglearnresearchcommunity

for

Search:↓

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

TNF-${\alpha}$ slows hair growth, and minoxidil doesn't help.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Different genes are linked to various types of hair loss.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.